Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://link.springer.com/article/10.1007/s11892-018-1043-z/fulltext.html
Reference78 articles.
1. Global burden of diabetes. International Diabetes Federation. Diabetic atlas fifth edition 2011, Brussels. http://www.diabetesatlas.org/ .
2. Long AN, Dagogo-Jack S. The comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens. 2011;13(4):244–51.
3. American Diabetes Association. Standards of medical care in diabetes-2016, lifestyle management. Diabetes Care. 2017;40(1):S33–43.
4. American Diabetes Association. Standards of medical care in diabetes-2016, cardiovascular disease and risk management. Diabetes Care. 2017;40(1):S75–87.
5. Gourgari E, Wilhem EE, Hassanzadeh H, et al. A comprehensive review of the FDA-approved labels of diabetes drugs: indications, safety, and emerging cardiovascular safety data. J Diabetes Complicat. 2017;31:1719–27.
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New Antidiabetic Agents for the Treatment of Heart Failure in Hypertensive Patients;Updates in Hypertension and Cardiovascular Protection;2023
2. Glucagon‐like peptide‐1 receptor agonist treatment of high carbohydrate intake‐induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca 2+ abnormalities and mitochondrial dysfunction;Clinical and Experimental Pharmacology and Physiology;2021-10-27
3. Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine;Frontiers in Psychiatry;2021-09-07
4. Therapeutic potential of targeting intestinal bitter taste receptors in diabetes associated with dyslipidemia;Pharmacological Research;2021-08
5. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?;Current Obesity Reports;2021-01-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3